Free Trial

MetLife (MET) Stock Price, News & Analysis

MetLife logo
$86.60 +1.41 (+1.66%)
(As of 11/22/2024 ET)

About MetLife Stock (NYSE:MET)

Key Stats

Today's Range
$84.79
$86.79
50-Day Range
$77.38
$86.60
52-Week Range
$62.81
$86.94
Volume
3.27 million shs
Average Volume
3.32 million shs
Market Capitalization
$59.96 billion
P/E Ratio
17.46
Dividend Yield
2.52%
Price Target
$88.46
Consensus Rating
Buy

Company Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.

MetLife Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
100th Percentile Overall Score

MET MarketRank™: 

MetLife scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 922 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MetLife has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 13 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MetLife has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about MetLife's stock forecast and price target.
  • Earnings Growth

    Earnings for MetLife are expected to grow by 15.75% in the coming year, from $8.38 to $9.70 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MetLife is 17.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 132.56.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MetLife is 17.46, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 47.55.

  • Price to Earnings Growth Ratio

    MetLife has a PEG Ratio of 0.75. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    MetLife has a P/B Ratio of 1.92. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about MetLife's valuation and earnings.
  • Percentage of Shares Shorted

    1.00% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently decreased by 31.08%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MetLife pays a meaningful dividend of 2.64%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    MetLife has been increasing its dividend for 11 years.

  • Dividend Coverage

    The dividend payout ratio of MetLife is 43.95%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, MetLife will have a dividend payout ratio of 22.47% next year. This indicates that MetLife will be able to sustain or increase its dividend.

  • Read more about MetLife's dividend.
  • Percentage of Shares Shorted

    1.00% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently decreased by 31.08%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MetLife has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 27 news articles for MetLife this week, compared to 18 articles on an average week.
  • Search Interest

    Only 18 people have searched for MET on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 80% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MetLife insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.31% of the stock of MetLife is held by insiders.

  • Percentage Held by Institutions

    89.81% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MetLife's insider trading history.
Receive MET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter.

MET Stock News Headlines

Giants vs. Buccaneers: 3 best prop bets for Week 12
Blackrock’s Sending THIS Crypto Higher on Purpose
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
See More Headlines

MET Stock Analysis - Frequently Asked Questions

MetLife's stock was trading at $66.13 at the beginning of 2024. Since then, MET shares have increased by 31.0% and is now trading at $86.60.
View the best growth stocks for 2024 here
.

MetLife, Inc. (NYSE:MET) posted its quarterly earnings data on Wednesday, July, 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.15. The firm's quarterly revenue was up 7.2% on a year-over-year basis.
Read the conference call transcript
.

MetLife's board approved a stock repurchase plan on Wednesday, May 1st 2024, which allows the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's leadership believes its shares are undervalued.

The following companies are subsidiaries of MetLife: Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and others.

Top institutional investors of MetLife include State Street Corp (3.86%), Wellington Management Group LLP (2.68%), Geode Capital Management LLC (1.70%) and Pzena Investment Management LLC (1.39%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar, Jeh C Johnson and Michel Khalaf.
View institutional ownership trends
.

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Exxon Mobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

Last Earnings
7/31/2024
Ex-Dividend for 9/10 Dividend
8/06/2024
Dividend Payable
9/10/2024
Ex-Dividend for 12/16 Dividend
11/05/2024
Today
11/22/2024
Dividend Payable
12/16/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
1/29/2025

Industry, Sector and Symbol

Sector
Finance
Industry
Life insurance
Sub-Industry
Life & Health Insurance
CUSIP
59156R10
Employees
45,000
Year Founded
1868

Price Target and Rating

Average Stock Price Target
$88.46
High Stock Price Target
$97.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+3.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Net Income
$1.58 billion
Pretax Margin
7.26%

Debt

Sales & Book Value

Annual Sales
$66.91 billion
Cash Flow
$6.98 per share
Book Value
$45.01 per share

Miscellaneous

Free Float
690,273,000
Market Cap
$59.45 billion
Optionable
Optionable
Beta
1.05

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NYSE:MET) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners